Arterial Stiffness and Wave Reflections in Patients With Sickle Cell Disease
- 1 December 2004
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 44 (6) , 924-929
- https://doi.org/10.1161/01.hyp.0000148506.73622.ba
Abstract
We tested the hypothesis that lower blood pressure and increased vasodilatation reported in sickle cell disease (SCD) patients with hemoglobin SS genotype (SS) are translated by lower arterial stiffness determined by pulse wave velocity (PWV) and wave reflections assessed by augmentation index (AI). We enrolled 20 SS (8 females; 12 male) patients closely matched for age, gender, height, and body mass index to 20 subjects with hemoglobin AA genotype (AA). Carotid–femoral PWV (PWV CF ) and carotid–radial PWV (PWV CR ) were recorded with the Complior device. Aortic AI was derived from pressure wave analysis (SphygmocoR). PWV CF and PWV CR were lower in SS than in AA (4.5±0.7 m/s versus 6.9±0.9 m/s, P P P =0.02). Multivariate analysis revealed that both PWV CF and PWV CR were negatively associated with hemoglobin SS type and positively related to mean arterial pressure (MAP), whereas AI was positively associated with MAP and total cholesterol (all P CF and PWV CR with age but a negative association with MAP ( R 2 =0.57 and 0.51, respectively, both P R 2 =0.65, P <0.001). This study provides the first evidence that SCD is associated with both lower arterial stiffness and wave reflections. SS patients have a paradoxical negative association between PWV and MAP, suggesting that low MAP does not protect them against arterial stiffness impairment.Keywords
This publication has 25 references indexed in Scilit:
- Arginine TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Arterial Stiffness and Endothelial Function in Patients With β-Thalassemia MajorCirculation, 2002
- Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell diseaseNature Medicine, 2002
- Reproducibility of derived central arterial waveforms in patients with chronic renal failureClinical Science, 2002
- Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell diseaseProceedings of the National Academy of Sciences, 2001
- Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietinProceedings of the National Academy of Sciences, 2000
- Blood Pressure in Acute Vaso-occlusive Crises of Sickle Cell DiseaseSouthern Medical Journal, 2000
- Influence of Body Height on Pulsatile Arterial Hemodynamic Data 11Financial support for this study was provided by Groupe d’Etude Physiopathologie Insuffisance Renale, Fleury Mérogis and by Laboratoires Synthelabo, Meudon-La-Foret, France.Journal of the American College of Cardiology, 1998
- Natural History of Blood Pressure in Sickle Cell Disease: Risks for Stroke and Death Associated with Relative Hypertension in Sickle Cell AnemiaThe American Journal of Medicine, 1997
- The metabolites of nitric oxide in sickle‐cell diseaseBritish Journal of Haematology, 1995